对免疫微环境和骨髓瘤免疫治疗机制的新见解
Cong Luo1, Xingxing Min1, Danying Zhang2
1Department of Orthopedic Trauma, Zhuji People's Hospital of Zhejiang Province, Zhuji, Zhejiang, China.
Frontiers in immunology
|February 3, 2025
概括
骨髓瘤是一种骨癌,结果不佳,特别是转移. 免疫疗法通过利用免疫系统对抗骨髓瘤提供了新的希望,可能提高生存率.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 生物医学研究生物医学研究
背景情况:
- 骨髓瘤是一种主要影响青少年的骨癌.
- 高侵袭性和肺转移导致预后不佳,生存率约为20%.
- 目前的手术和化疗等治疗方法在治疗转移性疾病方面存在局限性.
研究的目的:
- 审查骨髓瘤的生物特征.
- 探索骨髓瘤中肺转移的机制.
- 总结一下骨髓瘤免疫治疗的最新进展及其与标准治疗的结合.
主要方法:
- 骨髓瘤生物学,转移和瘤免疫微环境 (TME) 的文献综述.
- 对当前免疫疗法策略的分析,包括单克隆抗体,疫苗,细胞疗法,检查点抑制剂和型病毒.
- 讨论免疫疗法与传统治疗方法的整合.
主要成果:
- 骨髓瘤表现出复杂的生物特征和转移潜力.
- 瘤免疫微环境 (TME) 在骨髓瘤进展中起着关键作用.
- 在临床前和临床环境中,各种免疫疗法方法显示出有前途.
结论:
- 免疫疗法是治疗骨髓瘤的一个有希望的途径,特别是在管理转移方面.
- 结合不同的免疫疗法或将其与标准治疗相结合可能会提高疗效.
- 进一步研究骨髓瘤的TME和免疫疗法组合对于改善患者的治疗结果至关重要.
相关概念视频
02:17The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
01:27Tumor Immunotherapy
464
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
464
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K